drugset / Trial / NCT00277589

LISA-study : Levothyroxin in Nodular Goiter

NCT00277589 ↗

Phase 4 Completed 1024 enrolled Sanofi
RandomizedParallel-groupSingle-blindTreatment

Summary

Primary objective: * To evaluate change in total volume of all nodules. Secondary objectives: * To evaluate change in goiter volume after a 12-months treatment, number of nodules and echogenicity of nodules.

Timeline

Start
2004-05
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Iodide Small molecule — —
Comparator Levothyroxin-Na Unknown — —

Indications